These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

778 related items for PubMed ID: 17681368

  • 1. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
    Bohle B, Kinaciyan T, Gerstmayr M, Radakovics A, Jahn-Schmid B, Ebner C.
    J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
    [Abstract] [Full Text] [Related]

  • 2. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C, Slotosch C, Löffler H, Jakob T, Hertl M, Pfützner W.
    J Immunol; 2010 Feb 15; 184(4):2194-203. PubMed ID: 20048125
    [Abstract] [Full Text] [Related]

  • 3. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.
    Savolainen J, Jacobsen L, Valovirta E.
    Allergy; 2006 Oct 15; 61(10):1184-90. PubMed ID: 16942566
    [Abstract] [Full Text] [Related]

  • 4. Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls.
    Thunberg S, Akdis M, Akdis CA, Grönneberg R, Malmström V, Trollmo C, van Hage M, Gafvelin G.
    Clin Exp Allergy; 2007 Aug 15; 37(8):1127-36. PubMed ID: 17651141
    [Abstract] [Full Text] [Related]

  • 5. The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice.
    Winkler B, Hufnagl K, Spittler A, Ploder M, Kállay E, Vrtala S, Valenta R, Kundi M, Renz H, Wiedermann U.
    Allergy; 2006 Feb 15; 61(2):173-80. PubMed ID: 16409192
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I, König B, Böttcher I, Knop J, Saloga J.
    Clin Exp Allergy; 2006 Dec 15; 36(12):1546-55. PubMed ID: 17177678
    [Abstract] [Full Text] [Related]

  • 7. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season.
    Grindebacke H, Wing K, Andersson AC, Suri-Payer E, Rak S, Rudin A.
    Clin Exp Allergy; 2004 Sep 15; 34(9):1364-72. PubMed ID: 15347368
    [Abstract] [Full Text] [Related]

  • 8. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
    Geroldinger-Simic M, Kinaciyan T, Nagl B, Baumgartner-Durchschlag U, Huber H, Ebner C, Lidholm J, Bartel D, Vieths S, Jahn-Schmid B, Bohle B.
    J Allergy Clin Immunol; 2013 Jan 15; 131(1):94-102. PubMed ID: 22921871
    [Abstract] [Full Text] [Related]

  • 9. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L, Santarlasci V, Angeli R, Liotta F, Maggi L, Frosali F, Rossi O, Falagiani P, Riva G, Romagnani S, Annunziato F, Maggi E.
    Clin Exp Allergy; 2006 Mar 15; 36(3):261-72. PubMed ID: 16499636
    [Abstract] [Full Text] [Related]

  • 10. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
    Wang LH, Lin YH, Yang J, Guo W.
    Int Arch Allergy Immunol; 2009 Mar 15; 148(3):199-210. PubMed ID: 18849611
    [Abstract] [Full Text] [Related]

  • 11. Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production.
    Burastero SE, Mistrello G, Falagiani P, Paolucci C, Breda D, Roncarolo D, Zanotta S, Monasterolo G, Rossi RE.
    Ann Allergy Asthma Immunol; 2008 Apr 15; 100(4):343-50. PubMed ID: 18450120
    [Abstract] [Full Text] [Related]

  • 12. Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice.
    Wagner A, Förster-Waldl E, Garner-Spitzer E, Schabussova I, Kundi M, Pollak A, Scheiner O, Joachim A, Wiedermann U.
    Int J Parasitol; 2009 Mar 15; 39(4):465-72. PubMed ID: 18938169
    [Abstract] [Full Text] [Related]

  • 13. Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers.
    Gardner LM, Thien FC, Douglass JA, Rolland JM, O'Hehir RE.
    Clin Exp Allergy; 2004 Aug 15; 34(8):1209-19. PubMed ID: 15298560
    [Abstract] [Full Text] [Related]

  • 14. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy.
    Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA.
    Eur J Immunol; 2003 May 15; 33(5):1205-14. PubMed ID: 12731045
    [Abstract] [Full Text] [Related]

  • 15. Allergen provocation increases TH2-cytokines and FOXP3 expression in the asthmatic lung.
    Thunberg S, Gafvelin G, Nord M, Grönneberg R, Grunewald J, Eklund A, van Hage M.
    Allergy; 2010 Mar 15; 65(3):311-8. PubMed ID: 19845574
    [Abstract] [Full Text] [Related]

  • 16. The T cell response to major grass allergens is regulated and includes IL-10 production in atopic but not in non-atopic subjects.
    Domdey A, Liu A, Millner A, Lund K, Jacobi H, Malling HJ, Søndergaard I, Würtzen PA.
    Int Arch Allergy Immunol; 2010 Mar 15; 152(3):243-54. PubMed ID: 20150742
    [Abstract] [Full Text] [Related]

  • 17. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C, Ipsen H, Mayer L, Slotosch C, Petersen A, Würtzen PA, Hertl M, Pfützner W.
    J Allergy Clin Immunol; 2012 Nov 15; 130(5):1108-1116.e6. PubMed ID: 23021882
    [Abstract] [Full Text] [Related]

  • 18. Immune mechanisms of allergen-specific sublingual immunotherapy.
    Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Van Overtvelt L.
    Allergy; 2006 Feb 15; 61(2):151-65. PubMed ID: 16409190
    [Abstract] [Full Text] [Related]

  • 19. Allergen-specific IL-10-secreting type I T regulatory cells, but not CD4(+)CD25(+)Foxp3(+) T cells, are decreased in peripheral blood of patients with persistent allergic rhinitis.
    Han D, Wang C, Lou W, Gu Y, Wang Y, Zhang L.
    Clin Immunol; 2010 Aug 15; 136(2):292-301. PubMed ID: 20403730
    [Abstract] [Full Text] [Related]

  • 20. TLR2 agonists enhance CD8+Foxp3+ regulatory T cells and suppress Th2 immune responses during allergen immunotherapy.
    Tsai YG, Yang KD, Niu DM, Chien JW, Lin CY.
    J Immunol; 2010 Jun 15; 184(12):7229-37. PubMed ID: 20483759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.